These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3069624)

  • 21. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer].
    Garin AM; Dmitrieva NV; Vyshinskaia GV; Lichintser MR
    Vopr Onkol; 1987; 33(11):13-7. PubMed ID: 3686916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adjuvant hormone therapy of breast neoplasms. A critical review of the literature and perspectives].
    Boccardo F; Valenti G; De Menech R; Zanardi S
    Minerva Ginecol; 1986; 38(7-8):659-65. PubMed ID: 3528926
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adjuvant therapy of breast cancer. 1: Cytostatic therapy].
    Possinger K; Sauer HJ; Wilmanns W
    Fortschr Med; 1986 Aug; 104(29):552-5. PubMed ID: 3758881
    [No Abstract]   [Full Text] [Related]  

  • 25. An overview of contemporary management of breast carcinoma.
    Suhrland LG
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):783-96. PubMed ID: 3323974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant treatment of breast cancer].
    Goldhirsch A; Castiglione M
    Gynakol Rundsch; 1988; 28 Suppl 1():65-75. PubMed ID: 3042536
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy and hormone therapy of metastatic breast cancer.
    Paterson AH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
    Rose C; Kamby C; Mouridsen HT; Bastholt L; Brincker H; Skovgaard-Poulsen H; Andersen AP; Loft H; Dombernowsky P; Andersen KW
    Breast Cancer Res Treat; 1986; 7 Suppl():S45-50. PubMed ID: 3527306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aromatase inhibitors in the adjuvant therapy of breast cancer].
    Bauerschlag D; Schem C; Maass N; Jonat W
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):132-6. PubMed ID: 15990437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problems related to inflammatory cancers of the breast].
    Rouëssé J
    Pathol Biol (Paris); 1989 Feb; 37(2):140-1. PubMed ID: 2652065
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adjuvant treatment].
    Alberto P
    Pathol Biol (Paris); 1989 Feb; 37(2):134-6. PubMed ID: 2652063
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on cancer chemotherapy: general considerations and breast cancer. Part II.
    Wright JC
    J Natl Med Assoc; 1985 Sep; 77(9):691-703. PubMed ID: 3903172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormones in gynecologic oncology].
    Maass H
    Arch Gynecol Obstet; 1989; 245(1-4):466-73. PubMed ID: 2802734
    [No Abstract]   [Full Text] [Related]  

  • 37. Antioestrogens in the management of hormone-dependent cancer.
    Litherland S; Jackson IM
    Cancer Treat Rev; 1988 Sep; 15(3):183-94. PubMed ID: 3061640
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic adjuvant therapy for node-negative breast cancer: proven or premature?
    Pritchard KI
    Ann Intern Med; 1989 Jul; 111(1):1-4. PubMed ID: 2660644
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment decisions in breast cancer.
    Gore SM; Langlands AO; Spiegelhalter DJ; Stewart HJ
    Recent Results Cancer Res; 1988; 111():149-70. PubMed ID: 3051226
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant therapy in node-negative breast cancer. A panel discussion.
    McGuire WL; Abeloff MD; Fisher B; Glick JH; Henderson IC; Osborne CK
    Breast Cancer Res Treat; 1989 Mar; 13(2):97-115. PubMed ID: 2659105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.